chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT STARTED FEELING SUBJECTIVE FEVER SYMPTOMS THE MORNING AFTER IMMUNIZATION. SHE REPORTED FEVER, CHILLS, AND MALAISE FOR THE NEXT 48 HOURS, PRIMARILY STAYING IN BED FOR THAT DURATION. SHE TOOK TYLENOL TO HELP WITH SYMPTOMS DURING THAT TIME. SHE NOTED SOME MILD INJECTION SITE PAIN/SORENESS BUT IT WAS LESS THAN SHE EXPERIENCED AFTER HER FIRST DOSE.
Tinnitus, both ears. Blood pressure monitoring revealed normal results, not elevated.  Standard blood tests revealed no abnormalities. Pending referral to ENT specialist.
Erythema 4 inches and swelling about 4 inches wide over anterior aspect of right thigh with itching.  Benadryl and Keflex given.
No adverse effects after Dose #1. Shortly after Dose #2, I experienced the following problems: severe fatigue, slight headache, vision  (eye focusing problem) balancing, lack of coherence, slowed mental ability, lack of concentration, funny feeling in center of head e.g. my sinuses , increased heart rate, tightness in chest. All symptoms remain except  for severe fatigue and headache.  Sinus pressure, mental coherence, malaise and elevated heart rate continue.
Within a couple of hours he had a headache and a rash. The next day he had paleness, weak, throat hurt, and hives from head to toe. This was Christmas and Christmas eve on the 26th took him to MD said definite allergic reaction. Gave him a shot in his butt. It took two weeks for hives to finally go away. They got him on steroids also. Awful experience.
CHEST HURTS; SHORTNESS OF BREATH; SHAKING INTENSELY; SORE MUSCLES IN LEGS; FEVER RISING EVERY 20 MINUTES; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 12:40) dose was not reported, on 05-MAR-2021 at 17:00 for prophylactic vaccination. No concomitant medications were reported.  On 05-MAR-2021 at 21:30 the subject experienced chest hurts, shortness of breath, shaking intensely/chills, sore muscles in legs,  fever rising every 20 minutes and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from shaking intensely, and shortness of breath, and had not recovered from sore muscles in legs, fever rising every 20 minutes, chest hurts, and headache. The reporter assessed the events as related to  covid-19 vaccine ad26.cov2.s. This report was non-serious.
Noticed spots on her back at bathtime on 2/04/2010. This morning they had spread.
A phone call was made to the patient a couple days after her second vaccination and she reported that she had experienced dizziness, confusion, body aches and chills starting the night of her vaccination.
Red itchy rash area slightly below injection  site about 2 x 2"    Very slightly swollen.
Chest heaviness, throat tightness, sore throat, increase sinus drainage, headache, back pain, fatigue. Felt absolutely horrible.
10/19/2011 - AFLURIA given about 830AM in left arm. Patient came back to my office about 1:30pm to say her eyes were red, but no other problems (ie/breathing difficulty, etc) told her I was going to fill out VAERS form & to keep me posted. Followed up w/patient this morning, she has MD appointment.
4/20/2015: 69-year-old female comes to the emergency department with complaint of a wound on her right lower leg that she received today. Patient reports she was at work, stacking baskets and the stack tipped forward, scraping her lower leg. Denies hitting her head or receiving any other injuries in the incident. Pt reports the area is mildly painful. Sts she is experiencing a 5/10 aching pain in her shin that does not radiate. Pt reports she has been able to walk normally. Patient is unsure when she had her last tetanus and thinks it was many years ago. Patient reports she has diet-controlled diabetes. Patient was administered Tdap on 4/20/15 via intramuscular inj. 4/23/2015: 69 year old female presents today to the ED with complaints of right arm pain at the site of the Tdap injection. Patient states that she was seen on 04/20/2015 after sustaining a laceration and received a tetanus shot. Patient states that since then she has had pain in her arm. Patient rates the pain as a 6/10, constant and aching in nature. Patient has tried ADVIL at home with some relief. Patient denies fever or chills. Right upper arm, lateral aspect with area of erythema, warmth and swelling, no induration or fluctuance, no lymphangitis. Patient was discharged from the ER to home with a prescription of cephalexin 500mg po TID for 21 doses.
One day after giving the second dose of VARIVAX patient develops clinical varicella. I feel it's too early for the vaccine strain to do this. I believe it's a wild strain case of varicella. Lesions are scattered on chest & trunk & arms & itchy. T 102 today.
Consistent headache, elevated heart rate (while resting and in movement), fever, full-body chills, joint pain, body aches, sweaty palms and feet.
PATIENT SAID SHE WOKE UP THE MORNING AFTER RECEIVING THE SHOT WITH  A PAINFUL ARM THAT WAS WARM TO THE TOUCH. LATER THAT DAY (ABOUT 24 HOURS FROM RECEIVING THE SHOT) HER INNER ARM BELOW THE INJECTION SITE WAS WARM, SWOLLEN AND FIRM TO THE TOUCH. AT THE TIME I SAW HER ARM ON THURSDAY 6/10/21 IN THE AFTERNOON IT WAS THE SAME AS  DESCRIBED IT BEING WHEN IT FIRST OCCURED. SHE SAID IT HAD NOT CHANGED, BETTER OR WORSE, FROM WEDNESDAY. SHE LEFT TO GO HOME AND WAS GOING TO CHECK IN WITH HER DOCTOR. I NOTIFIED THE DOCTORS OFFICE  AS WELL AFTER SHE LEFT.
Pt received vaccine on 03/16.  Pt began with c/o congestion, runny nose, sneezing, loss of smell and taste and HA on 04/16.  Pt tested as part of routine surveillance for job at Long Term Care Facility.  Pt rapid antigen positive 04/16/2021.
Flu like symptoms; This case was reported by a physician via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable.  The physician asked so why do some people get flu symptoms after the second (booster) dose of Shingrix The reporter did not consent to follow up. As no further information was available.
Almost looked like cellulitis; Completely swollen about the side of a baseball; Arm was hot red; Arm was really hot; It was itching; Rash; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot) and VACCINATION SITE PRURITUS (It was itching) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot), VACCINATION SITE PRURITUS (It was itching) and VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION SITE CELLULITIS (Almost looked like cellulitis), VACCINATION SITE SWELLING (Completely swollen about the side of a baseball), VACCINATION SITE ERYTHEMA (Arm was hot red), VACCINATION SITE WARMTH (Arm was really hot), VACCINATION SITE PRURITUS (It was itching) and VACCINATION SITE RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  No treatment were reported
Information has been received from a registered pharmacist concerning a 77-year-old male who on 02-OCT-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck). The patient sought medical attention via a phone call with the pharmacist. The pharmacist stated it was product confusion. It was reported the vials looked similar and both vaccines were stored in the freezer. It was also reported the names sound similar. A product quality complaint was noted. Additional information is not expected.
LEFT ARM SWOLLEN AND REDDENED AROUND INJECTION SITE. VACCINES GIVEN ON 08/26/2008.           PT ADVISED TO APPLY COLD COMPRESSES TO LEFT ARM AND TO CALL BACK IF NO IMPROVEMENT.  PT. DOING FINE ON 08/29/2008. O SWELLING ON LEFT ARM.
TRANSIENT CEREBRAL ISCHEMIA 2/2/2023 INTERSTITIAL LUNG DISEASE ACUTE RESPIRATORY FAILURE 2/17/2023 INTERSTITIAL LUNG DISEASE TRANSIENT CEREBRAL ISCHEMIA 2/2/2023 PRESENCE OF BILIARY STENT ACUTE RESPIRATORY FAILURE 2/17/2023 PRESENCE OF BILIARY STENT
Extreme fatigue; Light dizziness; disorientation; Sore/stiff muscles, particularly lower extremities; Sore/stiff muscles, particularly lower extremities; This is a spontaneous report from a contactable consumer (Patient). A 44-year-old male patient received first dose of BNT162B2 (Pfizer COVID Vaccine, solution for injection, Lot# EN6202), via an unspecified route of administration, administered in left arm on 23Feb2021 at 05:00 AM (at the age of 44-years) as single dose for COVID-19 immunisation. Medical history included sleep apnea, headache and CALM supplement. The patient had no known allergies. Concomitant medication(s) included naproxen sodium for headache. On 23Feb2021 at 06:15 (1-hour and 15-minutes after vaccination), patient experienced extreme fatigue, light dizziness, disorientation, sore/stiff muscles, particularly lower extremities. The patient had not taken any other vaccine four weeks prior vaccination. The patient not had COVID-19 prior vaccination and was not tested for COVID-19 post vaccination. The outcome of the events was not recovered.
This spontaneous report was received from a registered nurse. It was reported that RECOMBIVAX HB had been administered to an unspecified number of patients between 23-AUG-2012 and 04-SEP-2012 when the temperature had not been recorded and stability might have been compromised. Lot# was not provided. It was unspecified if the patients sought medical attention. No adverse events had been reported. This is one of several reports received from the same source: 1209USA002392 1210USA000958 1210USA000959 1210USA000961 1210USA000962. Additional information has been requested.
Hives, minimal swelling and redness at site. Tylenol/or Ibuprofen ice 20 min max prn. pt's mom administered Benadryl to counter reaction.
PATIENT DID NOT SHOW FOR SECOND DOSE OF VACCINE WHEN CALLED WE WERE TOLD BY HIS WIFE THAT HE HAD A HEARTATTACK AND PASSED AWAY ON 04/13/2021
Immediately turned red, sweaty, increased heart rate, low blood pressure. Returned to normal, we went home. A couple hours later nauseous, fever of 101.1. Have Tylenol checked an hour later fever of 104. Started to douse him with ice cold wash cloths. Did that for two hours while continuing to monitor temp. Finally came down to 100.6. Let him sleep after taking more Tylenol. Fever of 99.3 upon waking in morning with headache and yucky feeling. Upon advise of friend gave Claritin and another Tylenol. He felt better. No fever the rest of the night and none sense.
Pt with dizziness, headache vertigo, nausea, vomiting and arm pain, generalize paresthesias starting Sunday after pt had injection on Thursday Localized swelling at injection site, below patients deltoid on left arm.
covid 19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (covid 19) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for COVID-19 prophylaxis: Spikevax (Dose 2) and Spikevax (Dose 1). Past adverse reactions to the above products included No adverse event with Spikevax and Spikevax. Concurrent medical conditions included Autoimmune disorder and Hashimoto's thyroiditis. Concomitant products included LEVOTHYROXINE SODIUM (UNITHROID) for Hashimoto's thyroiditis.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2022, the patient experienced COVID-19 (covid 19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (covid 19) outcome was unknown.            It was reported that it came out later that people with thyroid disease should not get the vaccine. Caller did not go get the recent one because it affects the results.
Anemic; Swelling; HUMIRA STOPPED WORKING AFTER COVID VACCINE; This spontaneous case was reported by a consumer and describes the occurrence of ANAEMIA (Anemic), SWELLING (Swelling) and THERAPEUTIC PRODUCT EFFECT DECREASED (HUMIRA STOPPED WORKING AFTER COVID VACCINE) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included PREDNISONE for an unknown indication.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced ANAEMIA (Anemic), SWELLING (Swelling) and THERAPEUTIC PRODUCT EFFECT DECREASED (HUMIRA STOPPED WORKING AFTER COVID VACCINE). At the time of the report, ANAEMIA (Anemic), SWELLING (Swelling) and THERAPEUTIC PRODUCT EFFECT DECREASED (HUMIRA STOPPED WORKING AFTER COVID VACCINE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Systemic: Headache-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe, Additional Details: advised pt mom to get tylenol and emetrol.  if problems persist, recommended to go to urgent care
Male consumer states that he has had 4 Pfizer Covid 19 vaccines and at the same time developed Idiopathic Peripheral Neuropathy/His brother has also had 4 Pfizer shots and has the same issue.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team.  A male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, Single), for COVID-19 immunization; Bnt162b2 (Dose: 2, Single), for COVID-19 immunization; Bnt162b2 (Dose: 3, Single), for COVID-19 immunization.   The following information was reported: AUTONOMIC NEUROPATHY (medically significant), outcome "unknown", described as "Male consumer states that he has had 4 Pfizer Covid 19 vaccines and at the same time developed Idiopathic Peripheral Neuropathy/His brother has also had 4 Pfizer shots and has the same issue.". The events "male consumer states that he has had 4 pfizer covid 19 vaccines and at the same time developed idiopathic peripheral neuropathy/his brother has also had 4 pfizer shots and has the same issue." required physician office visit.  Clinical course: The male consumer stated that he has had 4 Pfizer COVID-19 vaccines and at the same time developed idiopathic peripheral neuropathy. He relayed that he has been to a Neurologist and Pediatrist and has not found any answers. He would like to know if there was information on this being reported with the vaccine or not. He stated that his brother has also had 4 Pfizer shots and has the same issue. He relayed that there was a disconnect because if you google idiopathic peripheral neuropathy and COVID vaccines then a lot of information came up.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt. reported redness on vaccination site (RD) 2 minutes after getting vaccinated.  Pt. is allergic to peanuts and her skin is sensitive.  Vital signs taken  BP 121/80, O2Sat 100%, HR 69, R 18.  At 11:50am redness is going away.  At 11:55am pt. stated she feels ok and wants to go home.  At 12:05pm pt. went home.
sore arm; tender; swollen arm; big red patch; swells up and looks like a big goose egg; swollen lymph nodes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), TENDERNESS (tender), PERIPHERAL SWELLING (swollen arm), ERYTHEMA (big red patch) and SWELLING (swells up and looks like a big goose egg) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), LOVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN) and BUSPIRONE for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), TENDERNESS (tender), PERIPHERAL SWELLING (swollen arm), ERYTHEMA (big red patch), SWELLING (swells up and looks like a big goose egg) and LYMPHADENOPATHY (swollen lymph nodes). The patient was treated with IBUPROFEN for Pain in arm and Swelling arm, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Pain in arm and Swelling arm, at an unspecified dose and frequency and AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AMOXICLAV) for Prophylaxis, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), TENDERNESS (tender), PERIPHERAL SWELLING (swollen arm), ERYTHEMA (big red patch), SWELLING (swells up and looks like a big goose egg) and LYMPHADENOPATHY (swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
the patient had almost killed; Initial information regarding this unsolicited valid serious social media from a consumer (patient) and transmitted to Sanofi on 04-Dec-2020.  This case involved a patient of unknown demographics who was almost killed (near death experience), while the patient received vaccine INFLUENZA VACCINE.  Relevant medical history included cannabis use.  Past medical treatment, vaccination details, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was almost got killed (near death experience), unknown latency following the administration of INFLUENZA VACCINE.  This event was assessed as medically significant as per important medical event (IME) list.  Relevant laboratory test was not reported.  Final diagnosis was near death experience.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  Information on the batch number was requested.; Sender's Comments: This case concerns a patient of unknown demographics who reportedle had a near death experience after vaccination with INFLUENZA VACCINE, produced by unknown manufacturer. The time to onset is unknown. Patient's medical condition included use of cannabis. Concomitant medication and laboratory tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
Improperly stored administered PROQUAD; This spontaneous report has been received from a licensed practical nurse concerning a patient of unknown age and ethnicity. The patient's concurrent conditions, known allergies/reactions, medical history and concomitant medications were not reported.   On 17-SEP-2020, the patient was vaccinated with an imporperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) (Lot # T013540 with expiration date on 17-OCT-2021; dosage regimen and route of administration not provided) (temperature excursion from 6 farenheit degree (F) to 14 F (average 11.7 F) for 25 minutes; no previous temperature excursions); for prophylaxis. The call was made by data logger.
recieved rotateq po 08/25/2008 and 07/07/2008 within 24 hrs of both pt had blood to stool resolved on own , no pain or other complications occurred. Dr ordered child not to receive next dose
After receiving the second Shingles vaccine, the next day I was covered in a full body rash.
Information received from a company representative who received information from a physician regarding a 16 year old male who on 17Jul2012 was vaccinated with his first dose of GARDASIL injection in his left lower arm in the deltoid region. It was reported that patient received his second dose of MENACTRA (Sanofi Pasteur) at the same time, in his left upper arm in the deltoid region. It was reported the GARDASIL injection was given below the MENACTRA injection. It was reported the patient experienced severe abdominal cramping for two days then recovered. The patient did not have any serious medical intervention; did not seek medical attention and recovered with no permanent adverse effects. It was reported that the patient informed his physician of the abdominal cramping at a later sick visit. The patient did not receive his second injection of GARDASIL due to being sick (symptoms not specified). Additional information has been requested.
pt recvd vax 7NOV95 devel pain, swelling & reddness @ inj site; pt used needle in an attempt to drain; started on Diclaxicillin 14NOV95 referred to MD 16NOV95 for poss draining;